Xilio Therapeutics Inc (NAS:XLO)
$ 1.21 -0.05 (-3.97%) Market Cap: 44.66 Mil Enterprise Value: 14.68 Mil PE Ratio: 0 PB Ratio: 0.95 GF Score: 21/100

Xilio Therapeutics Inc (XLO) Stock Estimates Data

Xilio Therapeutics Inc (XLO) 12 Month Price Targets

Xilio Therapeutics Inc (XLO) Analyst Rating